The latest closing stock price for Poseida Therapeutics as of September 19, 2024 is 3.61.
An investor who bought $1,000 worth of Poseida Therapeutics stock at the IPO in 2020 would have $-765 today, roughly -1 times their original investment - a -30.36% compound annual growth rate over 4 years.
The all-time high Poseida Therapeutics stock closing price was 16.25 on July 20, 2020.
The Poseida Therapeutics 52-week high stock price is 4.27, which is 18.3% above the current share price.
The Poseida Therapeutics 52-week low stock price is 1.83, which is 49.3% below the current share price.
The average Poseida Therapeutics stock price for the last 52 weeks is 2.92.
An investor who bought $1,000 worth of Poseida Therapeutics stock at the IPO in 2020 would have $-765 today, roughly -1 times their original investment - a -30.36% compound annual growth rate over 4 years.
The all-time high Poseida Therapeutics stock closing price was 16.25 on July 20, 2020.
The Poseida Therapeutics 52-week high stock price is 4.27, which is 18.3% above the current share price.
The Poseida Therapeutics 52-week low stock price is 1.83, which is 49.3% below the current share price.
The average Poseida Therapeutics stock price for the last 52 weeks is 2.92.